백승기

This profile gathers the share dealings of 백승기 in 쿼드메디슨, where the filings describe the role as chief executive. We count 10 filings; the first trade dates from 12 December 2025 and the latest from 26 October 2026.

The open-market record is one-sided, with 7 purchases and not one sale. No amount is published for 7 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 5 purchases and no sales on the market.

None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 26 October 2026 with a transaction in 쿼드메디슨. The latest purchase dates back some time: it was published 69 days ago, on 31 August 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.